10-QPeriod: Q1 FY2005

UNITEDHEALTH GROUP INC Quarterly Report for Q1 Ended Mar 31, 2005

Filed May 5, 2005For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed its 10-Q report for the period ending March 30, 2005, detailing significant share repurchase activity during the first quarter. The company actively bought back its own stock, demonstrating a commitment to returning value to shareholders and potentially boosting earnings per share. This proactive approach to capital allocation, alongside the routine filing of certifications and exhibits, signals a well-managed and transparent operation during this period. Investors can take note of the consistent share repurchase trend throughout January, February, and March 2005, indicating management's confidence in the company's valuation and future prospects. The ongoing share repurchase program, with a substantial authorization from the Board of Directors, suggests a continued focus on optimizing shareholder returns.

Key Highlights

  • 1UnitedHealth Group repurchased a total of 13,210,000 shares of its common stock in the first quarter of 2005.
  • 2The average price paid per share for these repurchases was $89.64.
  • 3All share repurchases in Q1 2005 were conducted as part of a publicly announced share repurchase program.
  • 4As of March 31, 2005, there were 41,380,000 shares that could yet be purchased under the existing plans or programs.
  • 5The company's share repurchase program, last renewed on November 4, 2004, authorized the repurchase of up to 65 million shares with no set expiration date.
  • 6The filing includes certifications pursuant to Section 302 and 906 of the Sarbanes-Oxley Act of 2002, indicating compliance with corporate governance regulations.
  • 7Several Form 8-K filings were made during the quarter, including announcements of Q4 earnings, executive compensation, investor meetings, and the issuance of company notes.

Frequently Asked Questions

UnitedHealth Group repurchased a total of 13,210,000 shares at an average price of $89.64 per share, totaling approximately $1.18 billion in the first quarter of 2005.

Yes, the share repurchase program is ongoing. As of March 31, 2005, the company had authorization to repurchase up to 41,380,000 additional shares under its publicly announced program, which has no established expiration date.

The certifications pursuant to Section 302 and 906 of the Sarbanes-Oxley Act of 2005 are important for investors as they affirm the accuracy and reliability of the company's financial reporting and the effectiveness of internal controls, signed by senior management.

During the first quarter of 2005, UnitedHealth Group filed several 8-K reports to announce fourth-quarter earnings, disclose executive incentive plan details, inform about investor and analyst meetings, and report the issuance of company notes.